Content Development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): Use of Qualitative and Quantitative Methods for Scale Construction von Wagner, Lynne I., PhD, Robinson, Don, MSPH, Weiss, Matthias, MD, Katz, Michael, MBA, Greipp, Phillip, MD, Fonseca, Rafael, MD, Cella, David, PhD

Volltext

A phase II trial of imatinib in patients with refractory relapsed myeloma von Dispenzieri, Angela, Gertz, Morie A., Lacy, Martha Q., Geyer, Susan M., Greipp, Phillip R., Rajkumar, S. Vincent, Kimlinger, Teresa, Lust, John A., Fonseca, Rafael, Allred, Jacob, Witzig, Thomas E.

Volltext

A novel report of cig‐FISH and cytogenetics in POEMS syndrome von Bryce, Alan H., Ketterling, Rhett P., Gertz, Morie A., Lacy, Martha, Knudson, Ryan A., Kumar, Shaji, Kyle, Robert A., Fonseca, Rafael, Greipp, Phillip R., Lust, John A., Rajkumar, Vincent S., Hayman, Suzanne R., Buadi, Francis, Russell, Stephen J., Zeldenrust, Stephen R., Dispenzieri, Angela

Volltext

A novel report of clg-FISH and cytogenetics in POEMS syndrome von BRYCE, Alan H, KETTERLING, Rhett P, RAJKUMAR, Vincent S, HAYMAN, Suzanne R, BUADI, Francis, RUSSELL, Stephen J, ZELDENRUST, Stephen R, DISPENZIERI, Angela, GERTZ, Morie A, LACY, Martha, KNUDSON, Ryan A, KUMAR, Shaji, KYLE, Robert A, FONSECA, Rafael, GREIPP, Phillip R, LUST, John A

Volltext

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma von Khan, Meaghan L., Reeder, Craig B., Kumar, Shaji K., Lacy, Marthy Q., Reece, Donna E., Dispenzieri, Angela, Gertz, Morie A., Greipp, Phillip, Hayman, Suzanne, Zeldenhurst, Steven, Dingli, David, Lust, John, Russell, Stephen, Laumann, Kristina M., Mikhael, Joseph R., Leif Bergsagel, P., Fonseca, Rafael, Vincent Rajkumar, S., Keith Stewart, A.

Volltext

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell von BILLADEAU, D, AHMANN, G, GREIPP, P, VAN NESS, B

Volltext

Comparable Survival in Newly Diagnosed Multiple Myeloma (MM) after VAD Induction with High Dose Therapy Using Melphalan 140mg/M2 + TBI 12 Gy (MEL+TBI) Versus Standard Therapy with... von Crowley, John, Fonseca, Rafael, Greipp, Phillip, Jason, McCoy, Bart, Barlogie

Volltext

14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH) von Bryce, Alan H., Ketterling, Rhett, Gertz, Morie, Zeldenrust, Steve, Lacy, Martha, Kumar, Shaji, Hayman, Suzanne, Buadi, Francis, Greipp, Phillip, Lust, John, Rajkumar, Vincent, Fonseca, Rafael, Dingli, David, Russell, Stephen, Kyle, Robert, Dispenzieri, Angela

Volltext

T‐helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93 von Kay, Neil E., Leong, Traci, Bone, Nancy, Kyle, Robert A., Greipp, Phillip R., Van Ness, Brian, Oken, Martin M.

Volltext

Altered T cell Repertoire Usage in CD4 and CD8 Subsets of Multiple Myeloma Patients, a Study of the Eastern Cooperative Oncology Group (E9487) von Kay, Neil, Leong, Traci, Kyle, Robert A., Greipp, Phillip, van Ness, Brian, Bone, Nancy, Oken, Martin M.

Volltext

Circulating CD19+ Blood Cell Levels in Myeloma von Kay, Neil E., Oken, Martin M., Bone, Nancy, Kyle, Robert A., Greipp, Phillip, Ness, Brian Van, Leong, Traci

Volltext